Prodia Diagnostic Line Tbk vs Bersama Zatta Jaya Tbk. — how do they compare? Prodia Diagnostic Line Tbk trades at Rp264 (market cap 470.58B, 18.86M 24h volume), while Bersama Zatta Jaya Tbk. trades at Rp68 (market cap 577.73B, 37.25M 24h volume). The key difference: Bersama Zatta Jaya Tbk. is the larger of the two by market cap, and Bersama Zatta Jaya Tbk. is more actively traded (37.25M versus 18.86M). Which is the better fit depends on your goals.
| PRDL | ZATA | |
|---|---|---|
Market Cap | 470.58B | 577.73B |
Volume | 18.86M | 37.25M |
Lot | 188.57K | 372.46K |
Turnover | 4.97B | 2.53B |
Average Price | 263.63 | 67.87 |
Value | 4.97B | 2.53B |
Indicative Equilibrium Price | 264 | 68 |
Indicative Equilibrium Volume | 3.64K | 9.2K |
Trailing returns across standard periods
Latest headlines on both assets
PT Prodia Diagnostic Line Tbk (the Company) was established April 16, 2010 with the name of PT DiaLine Systems Indonesia based on Notarial Deed No. 22 of Rismalena Kasri, S.H. On April 25, 2011, PT DiaLine Systems Indonesia changed the Companys name to PT Prodia Diagnostic Line based on Notarial Deed No. 14 of Rismalena Kasri, S.H. The Company is in the form of a Limited Liability Company in 2010 and began commercial production in 2011. The production results are marketed locally. The parent and ultimate parent entity of the Company is PT Prodia Utama.
Read more on PRDL →PT Bersama Zatta Jaya Tbk (the Company) was established based on notarial deed No. 39 datedApril 16, 2012 of Ermilla Ananta Cahyani,S.H., notary in Bandung. The company started its commercial activities since 2012.
Read more on ZATA →